Breakthrough in Cholesterol Treatment: FDA Approves First Oral PCSK9 Inhibitor
The US FDA has approved Lipfendra – the first medication for lowering 'bad' cholesterol that is taken in pill form rather than via injection. This opens a new era in cardiovascular disease therapy.